ushstat
Gene therapyexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2012 (NCT01505062)
Timeline
2010s
- Jan 1, 2012
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Unconventional myosin-VIIaSupplementation
supplementation - MYO7A
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ushstat
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02065011 | Phase 1/Phase 2 (Phase 2) | Sep 1, 2013 | Casey Eye Institute, Portland, Oregon, Sanofi |
| NCT01505062 | Phase 1/Phase 2 (Phase 2) | Mar 1, 2012 | Casey Eye Institute, Portland, Oregon, CHNO des Quinze-Vingts, Sanofi |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Casey Eye Institute, Portland, Oregon | Academic/Hospital | 2 | 0 | 1 | 2012 |
| Sanofi | For profit | 2 | 2 | 1 | 2012 |
| CHNO des Quinze-Vingts | Academic/Hospital | 1 | 0 | 1 | 2012 |
3 organizations
Page 1 / 1